Thomas C Reynolds's Net Worth
$8.87 Million
Who is Thomas C Reynolds?
Thomas C Reynolds has an estimated net worth of $8.87 Million. This is based on reported shares across multiple companies, which include SEATTLE GENETICS INC /WA, MEI Pharma, Inc., and Trillium Therapeutics Inc..
SEC CIK
Thomas C Reynolds's CIK is 0001393945
Past Insider Trading and Trends
2012 was Thomas C Reynolds's most active year for acquiring shares with 31 total transactions. Thomas C Reynolds's most active month to acquire stocks was the month of July. 2012 was Thomas C Reynolds's most active year for disposing of shares, totalling 56 transactions. Thomas C Reynolds's most active month to dispose stocks was the month of October. 2007 saw Thomas C Reynolds paying a total of $3,205,562.50 for 381,250 shares, this is the most they've acquired in one year. In 2012 Thomas C Reynolds cashed out on 812,154 shares for a total of $9,638,800.69, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SEATTLE GENETICS INC /WA (SGEN) No price found
Chief Medical OfficerThomas C Reynolds owns 57,601 units of Common Stock. From 2007 to 2013 Thomas C Reynolds acquired a total of 752,841 shares in SEATTLE GENETICS INC /WA at a cost of $7,066,644.90, Thomas also disposed a total of 704,207 shares of SEATTLE GENETICS INC /WA equalling to $15,906,557.07.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$21.57 | -$124,239.48 | 57.6K |
Scheduled
|
Jan 25 - Jan 28
| ||
Form 4
|
—
|
0
|
$19.81 | -$2,049,721.29 | 57.6K |
Scheduled
|
Jan 15
| ||
Form 4
|
—
|
0
|
$18.49 | -$970,145.08 | 57.6K |
Dec 6 - Dec 10
| |||
Form 4
|
—
|
0
|
$18.86 | -$538,700.00 | 57.6K |
Dec 4 - Dec 5
| |||
Form 4
|
—
|
0
|
$18.73 | -$534,901.26 | 57.6K |
Nov 29 - Dec 3
| |||
Form 4
|
—
|
0
|
$19.25 | -$365,500.00 | 57.6K |
Nov 21 - Nov 26
| |||
Form 4
|
—
|
0
|
$20.13 | -$192,687.64 | 57.6K |
Nov 19 - Nov 20
| |||
Form 4
|
—
|
0
|
$19.00 | -$1,044,095.40 | 57.6K |
Scheduled
|
Sep 6
| ||
Form 4
| +82.28% | 26K |
—
|
—
| 57.6K |
Aug 20
| |||
Form 4
|
—
|
0
|
$14.00 | -$10,922.99 | 31.07K |
Scheduled
|
May 15
| ||
Form 4
|
—
|
0
|
$14.00 | -$460,400.00 | 31.07K |
Scheduled
|
Apr 25
| ||
Form 4
|
—
|
0
|
$14.01 | -$461,500.00 | 31.07K |
Scheduled
|
Mar 22
| ||
Form 4
|
—
|
0
|
$14.00 | -$460,400.00 | 31.07K |
Scheduled
|
Mar 16 - Mar 19
| ||
Form 4
|
—
|
0
|
$14.00 | -$460,400.00 | 30.17K |
Scheduled
|
Jan 27
| ||
Form 4
| +1,221.46% | 27.89K |
—
|
—
| 30.17K |
Aug 19 - Aug 24
| |||
Form 4
| -50.84% | -1.54K |
$17.37 | -$26,732.43 | 1.49K |
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$14.90 | -$152,330.63 | 3.03K |
Scheduled
|
May 18 - May 19
| ||
Form 4
|
—
|
0
|
$13.02 | -$191,200.00 | 3.03K |
Scheduled
|
May 13
| ||
Form 4
| -38.76% | -1.92K |
$12.60 | -$119,567.49 | 3.03K |
Scheduled
|
Apr 29
| ||
Form 4
|
—
|
0
|
$12.60 | -$217,750.00 | 5.72K |
Scheduled
|
Oct 11
| ||
Form 4
|
—
|
0
|
$11.60 | -$167,750.00 | 5.72K |
Scheduled
|
Sep 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 27
| |||
Form 4
| -28.50% | -1.80K |
$10.60 | -$132,557.28 | 4.51K |
Scheduled
|
May 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 25
| |||
Form 4
|
—
|
0
|
$10.36 | -$105,725.00 | 3.71K |
Jul 30
| |||
Form 4
|
—
|
0
|
$10.38 | -$52,686.21 | 2.63K |
Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MEI Pharma, Inc. (MEIP) Snapshot price: $4.615
InvestorThomas C Reynolds owns 10,000 units of Common Stock which is worth $46,150.00. From 2013 to 2023 Thomas C Reynolds acquired a total of 10,000 shares in MEI Pharma, Inc. at a cost of $16,000.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
∞
| 10K |
$1.60 | $16,000.00 | 10K |
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trillium Therapeutics Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||